PMID: 92668Dec 22, 1979

Aspirin and secondary mortality after myocardial infarction

Lancet
P C Elwood, P M Sweetnam

Abstract

A randomised controlled double-blind trial of aspirin in the prevention of death was conducted in 1682 patients (including 248 women) who had had a confirmed myocardial infarct (MI). 25% of the patients were admitted to the trial within 3 days of the infarction and 50% within 7 days. Aspirin, 300 mg three times daily, was given for 1 yr. Total mortality was 12.3% in patients given aspirin and 14.8% in those given placebo, a reduction by aspirin of 17%, which was not statistically significant at p less than 0.05. The reduction in specific ischaemic-heart-disease (IHD) mortality was 22% and in total mortality plus IHD morbidity (readmission to hospital for MI in survivors) was 28%.

Citations

Dec 1, 1992·The Annals of Pharmacotherapy·L E McAnallyS F Hamilton
May 1, 1986·Journal of Clinical Pharmacology·C A CampbellR A Kloner
Mar 15, 1990·The New England Journal of Medicine·A J Moss, J Benhorin
Mar 10, 1983·The New England Journal of Medicine·D Wikler
Dec 1, 1981·Australian and New Zealand Journal of Medicine·P A Castaldi
Mar 16, 1981·Klinische Wochenschrift·E WalterP Oster
Sep 30, 1998·The British Journal of Surgery·R G GibbsA H Davies
Sep 27, 2002·The New England Journal of Medicine·Mette HurlenHarald Arnesen
Jun 8, 2011·Journal of General Internal Medicine·Scot H SimpsonThane Chambers
Sep 25, 2016·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Faraz Khan LuniSadik A Khuder
Feb 25, 1989·BMJ : British Medical Journal·P J PrichardC J Hawkey
Dec 1, 1985·Circulation·Garret A FitzGeraldA K Pedersen
Jul 19, 1980·British Medical Journal·B Lewis
Jul 18, 1981·British Medical Journal·S M Gore
Jan 1, 1980·Acta Neurologica Scandinavica. Supplementum·J E Olsson
Jan 1, 1981·Acta Medica Scandinavica. Supplementum·E ThaulowJ Erikssen
Jan 1, 1982·Annals of the New York Academy of Sciences·J Hirsh
Mar 1, 1993·British Journal of Clinical Pharmacology·P J RoderickT W Meade
Dec 9, 1998·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·M KleinE Gams
Apr 22, 1999·Postgraduate Medical Journal·P C ElwoodJ R O'Brien
Oct 27, 2004·Journal of Cardiovascular Pharmacology·Amy C Nulton-PerssonHesham A Sadek
Apr 12, 2005·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Jussi MikkelssonPekka J Karhunen
May 21, 2014·Clinical Pharmacology and Therapeutics·C D Williams
Apr 25, 2018·PharmacoEconomics Open·Laurence M DjatcheRobert D Lieberthal
May 1, 1985·Stroke; a Journal of Cerebral Circulation·M GentM Giroux-Klimek
Sep 15, 1988·The New England Journal of Medicine·J A OatesL J Roberts
Mar 1, 1981·Clinical Cardiology·G SchettlerK König
Apr 1, 1987·Australian and New Zealand Journal of Medicine·J D Parkin
Apr 1, 1989·Clinical Cardiology·J L Mehta, C R Conti
Nov 1, 1983·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·R L Kinlough-RathboneJ F Mustard
Feb 9, 1985·British Medical Journal·J R Hampton
Oct 1, 1986·Angiology·F NumanoF Numano
Jan 1, 1995·Medical Decision Making : an International Journal of the Society for Medical Decision Making·V Hasselblad, D C McCrory
Jan 1, 1993·Statistical Methods in Medical Research·J L Fleiss
Sep 1, 1995·British Heart Journal·J G ClelandG C Sutton
Dec 1, 1987·Drug Intelligence & Clinical Pharmacy·M M Rumore, G S Goldstein
Jun 7, 1980·British Medical Journal·B J Culliton, W K Waterfall
Jan 1, 1981·Current Medical Research and Opinion·J A Tulloch, T C Marr
May 23, 1981·British Medical Journal·S M Gore
Mar 15, 2000·Circulation·E H Awtry, J Loscalzo
Oct 24, 2000·Statistics in Medicine·K J Lui, C Kelly
Aug 6, 1999·Stroke; a Journal of Cerebral Circulation·Philip B GorelickC J Pepine
Oct 26, 2001·The Journal of International Medical Research·T TsudaK Ota
Dec 25, 2009·Circulation. Cardiovascular Quality and Outcomes·Jeffrey S BergerSylvia Wassertheil-Smoller
Jan 13, 2016·Current Atherosclerosis Reports·Michael D MiedemaSalim S Virani
Apr 1, 1988·British Journal of Pharmacology·R M Tripathi, R Kaushal
Nov 1, 1989·British Journal of Clinical Pharmacology·G K KitchingmanC J Hawkey
Dec 1, 1989·Cardiovascular Drugs and Therapy·B Stein, V Fuster
Jan 31, 1980·The New England Journal of Medicine·E Braunwald
Aug 1, 1985·British Journal of Haematology·F E Preston, M Greaves
Jan 1, 1981·Journal of Neurosurgery·S Wessler, S N Gitel
Sep 16, 1982·The New England Journal of Medicine·E.P.S.I.M. Research Group
Feb 24, 2006·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Deepak ThataiPatrick M Pullicino
Jul 16, 2005·Stroke; a Journal of Cerebral Circulation·Philip B Gorelick, Steven M Weisman
Mar 31, 2016·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Alexander C Fanaroff, Matthew T Roe
Apr 1, 1987·Statistics in Medicine·C H HennekensP R Hebert
Apr 14, 1999·The Annals of Pharmacotherapy·K H SongR Hoover
Sep 5, 1981·British Medical Journal·S M Gore
Jan 28, 2021·Annual Review of Medicine·Emanuela Ricciotti, Garret A FitzGerald
Nov 6, 2020·International Journal of Cardiology·Jaskanwal D S SaraAmir Lerman

Related Concepts

Zorprin
Clinical Trials
Sudden Death
Myocardial Infarction
Dropouts
Placebos

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

The Tendon Seed Network

Tendons are rich in the extracellular matrix and are abundant throughout the body providing essential roles including structure and mobility. The transcriptome of tendons is being compiled to understand the micro-anatomical functioning of tendons. Discover the latest research pertaining to the Tendon Seed Network here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Incretins

Incretins are metabolic hormones that stimulate a decrease in glucose levels in the blood and they have been implicated in glycemic regulation in the remission phase of type 1 diabetes. Here is the latest research.

Chromatin Regulation and Circadian Clocks

The circadian clock plays an important role in regulating transcriptional dynamics through changes in chromatin folding and remodelling. Discover the latest research on Chromatin Regulation and Circadian Clocks here.

Long COVID-19

“Long Covid-19” describes illness in patients who are reporting long-lasting effects of the SARS-CoV-19 infection, often long after they have recovered from acute Covid-19. Ongoing health issues often reported include low exercise tolerance and breathing difficulties, chronic tiredness, and mental health problems such as post-traumatic stress disorder and depression. This feed follows the latest research into Long Covid.

Spatio-Temporal Regulation of DNA Repair

DNA repair is a complex process regulated by several different classes of enzymes, including ligases, endonucleases, and polymerases. This feed focuses on the spatial and temporal regulation that accompanies DNA damage signaling and repair enzymes and processes.